- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05165576
Child-centered Communication and Anesthesia Use for MRI
October 18, 2023 updated by: Universidade do Porto
The Influence of Child-centered Communication on Children's Anxiety and Use of Anesthesia for MRI
The goal of this project is to study the influence of child-centered communication on children's anxiety, satisfaction and the use of anesthesia for MRI
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study seeks to inspect the influence of a child-centered communication (CCC) on anesthesia use in magnetic resonance imaging (MRI) exams among four- to 10-year-old children.
Children's levels of anxiety and satisfaction with the interaction also are assessed.
Children are divided into three groups by order of arrival.
Group 1 receives routine information about the MRI and simulates it with an MRI toy (EG1).
Group 2 simulates the exam with the toy and receives the CCC.
These two groups are compared with a third group of children who had received only the routine information about the exam and who served as a comparison group (CG).
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Porto, Portugal, 4200-319
- Centro Hospitalar Universitário de São João
-
Porto, Portugal, 4200-319
- Faculty of Medicine of the University of Porto
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 10 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Ages between four and 10 years old
- Having a medical request for the MRI in the hospital
- The MRI performed for the first time
Exclusion Criteria:
- Presenting cognitive, psychiatric or neurological conditions that prevented the understanding of communication
- Having any intra-body devices that impeded performance of the MRI exam
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Child-centered communication
The child's preparation for the MRI scanning is conducted using a child-centered communication type of interaction
|
The child is asked for ideas, fears and concerns regarding the magnetic resonance imaging exam and responses are tailored to these individual needs
|
|
Active Comparator: Magnetic Resonance Imaging (MRI) Simulation Toy
The child's preparation for the MRI scanning is conducted through provision of general information about the MRI exam simulated with an MRI toy
|
The child is asked for ideas, fears and concerns regarding the magnetic resonance imaging exam and responses are tailored to these individual needs
|
|
No Intervention: General information about the Magnetic Resonance Imaging (MRI) exam
The child's preparation for the MRI scanning is based on the provision of routine information about the MRI exam
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anesthesia count
Time Frame: 30 minutes (after the Magnetic Resonance Imaging)
|
Number of children who perform the Magnetic Resonance Imaging exam using anesthesia
|
30 minutes (after the Magnetic Resonance Imaging)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in self-reported anxiety
Time Frame: 20 minutes (before and after the child's preparation)
|
Change in anxiety levels before and after preparation for the Magnetic Resonance Imaging, assessed through a self-report question responded on a 1 ("very calm") to 5 ("very scared") scale
|
20 minutes (before and after the child's preparation)
|
|
Change in heart rate frequency
Time Frame: 20 minutes (before and after the child's preparation)
|
Change in anxiety levels before and after preparation for the Magnetic Resonance Imaging assessed through heart rate frequency
|
20 minutes (before and after the child's preparation)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction measurement
Time Frame: 20 minutes (after child preparation to do the Magnetic Resonance Imaging)
|
Children's satisfaction with the interaction they had in preparation for the Magnetic Resonance Imaging, assessed through self-reported, Yes/No questions
|
20 minutes (after child preparation to do the Magnetic Resonance Imaging)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Irene P Carvalho, PhD, Universidade do Porto
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2020
Primary Completion (Actual)
July 31, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
November 22, 2021
First Submitted That Met QC Criteria
December 6, 2021
First Posted (Actual)
December 21, 2021
Study Record Updates
Last Update Posted (Actual)
October 19, 2023
Last Update Submitted That Met QC Criteria
October 18, 2023
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CASTRO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data are confidential and will be shared only among the research team.
Aggregate data can be shared with others only for research purposes and without any identifiers that might compromise the participant's anonimity
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.